State Street Corporation 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-23 10:10 am Sale |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
STATE STREET CORP STT |
1,635,726 3.460% |
-871,262 (-34.75%) |
Filing |
| 2023-02-08 2:02 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
STATE STREET CORP STT |
2,506,988 5.760% |
2,506,988 (New Position) |
Filing |